Contract Research Organization Services (CROs) Market Size 2020, Share, Growth, Trends, Drivers, Restraints, Opportunities, and Global Industry Analysis 2027


Published Date : May 2020
Category : Pharmaceutical & Healthcare
Report Id : ReportCrux 028
Publisher Name : ReportCrux
Price : $2,999
No of Pages : 199

We are offering flat 20% discount on Contract Research Organization Services CROs Market with COVID-19 Impact Analysis

Market Size:

The global Contract Research Organization Services Market is estimated to grow from USD 44.4 Billion in 2019 to reach USD 91.7 Billion by 2027, at a CAGR of 9.5% during the forecast period from 2020-2027.

The evolving world has forced major pharmaceutical firms to outsource many of their vital operations including prescription drug and medical device testing and manufacturing. This has given the contract research organizations services market a favorable context to for growth.

Final Report will have an in-depth analysis of the COVID-19 impact on the Contract Research Organization Services Market.

Contract Research Organization Services Market by Type (Early Phase Development Services [Discovery Studies, and Chemistry, Manufacturing & Control], Preclinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing, and Others], Clinical Research Services [Phase I, Phase II, Phase III, and Phase IV], Laboratory Services [Bioanalytical Testing, and Stability Testing], Batch Release Testing, Analytical Testing, Physical Characterization, Raw Material Testing, Consulting Services, Data Management Services, and Other Analytical Testing); by Therapeutic Area (Oncology, CNS Disorders, Metabolic Disorders, Infectious Diseases, Respiratory Disorders, CVS Disorders, Immunological Disorders, Ophthalmology, and Other Therapeutic Areas); by End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, and Academic Institutes); and by Region: Global Industry Trends, Dynamics, Competitive Insights and Forecast Analysis, 2020 – 2027

Market Drivers, Restraining, Opportunities:

Drivers responsible for growth in the market include: • Increased Outsourcing of R&D Activities • Increasing Demand of Outsourcing Analytical Testing and Clinical Trial Services • Rise in Clinical Trials • Growing R&D Expenditures
Factors restraining market growth: • Regulatory Pressure on CROs • Increasing Competition in the CRO Industry
Market Opportunities include: • Rising Demand for Specialized Testing Services • Growing Biosimilars and Biologics Market



Key Player’s Analysis:

The report provides key player analysis along with company revenue shares in order to give a broader overview of the market players in the contract research organization services market. Major players in contract research organization services market are IQVIA (U.S.), WuXi AppTech (China), SGS (Switzerland), Charles River (U.S.), PAREXEL (U.S.), Syneos Health (U.S.), Medpace (U.S.), ICON Plc (Ireland), PPD (U.S.), and PRA Health Sciences (U.S.) among others.

Market Overview:

The market report covers a basic overview of the market from the industry perspective. This will help the reader to get a gist about different industry dimensions from a manufacturer’s view. The report divides the market into different sections and is comprised of market revenue (value) by segments.

The report provides market data from 2016 till 2027, wherein, 2016 to 2018 will be historic years, 2019 would be the base year and 2020 to 2027 will be forecast years. The report provides different statistics and figures and charts that will help analyze trends and global contract research organization services market share along with its growth rate in different regions and countries.

Key players across the globe are profiled in the report along with its company landscaping. Product portfolio for each company, recent developments and company strategies are covered along with the company financials.

Economy Trends & Strategic Analysis:

Various drivers, restraints and opportunities in the contract research organization services market are analyzed in detail in the report. Key drivers that make the overall market grow are discussed thoroughly, along with its impact on the sales of different offering types. Report also features restraining factors that are likely to restrain the market growth. As well, different opportunities which will propel the market in future and bring new growth avenues for major market players are discussed in detail. This will help in understanding the overall dynamics prevailing in the historic as well as in coming years.

Apart from this, the report covers various collaborations, mergers and acquisitions, regional expansions, new offering launches and offering pipelines for the key players involved in the market.

Segmental and Geographic Analysis:

The report describes in detail market segmentation by dividing the market based on its type, therapeutic area, end user, and region and is analyzed from 2016 to 2027 by value and volume. All the segments are evaluated by taking into consideration the historic and future trends. All the segments with the dominating & fastest growing sub-segments and the factors responsible for the same are studied and are mentioned in the report.

Evident quantitative as well as qualitative insights about the segments are covered in the report along with forecast analysis of all the segments that expected to alter the market in the future are described in detail. The segmental analysis also highlights details about different aspects that will influence the market.

Based on type, the market is segmented into early phase development services, clinical research services, laboratory services, consulting services and data management services. The early phase development services segment is further divided into discovery studies, chemistry, manufacturing & control and preclinical services. Preclinical services are classified into pharmacokinetics/pharmacodynamics (PK/PD), toxicology testing and others. The clinical research services segment is further divided into phase II, phase I, phase III, and phase IV. Laboratory services segment is further divided into bioanalytical testing and analytical testing. Analytical testing segment includes physical characterization, stability testing, batch release testing, raw material testing and other analytical testing. Based on the therapeutic area, the global market is segmented into oncology, CNS disorders, metabolic disorders, infectious diseases, respiratory disorders, CVS disorders, immunological disorders, ophthalmology, and other therapeutic areas. Based on end user, the global market is segmented into medical device companies, academic institutes, and pharmaceutical and biopharmaceutical companies.

Market is divided regionally and by country level into North America (U.S., Canada, & Rest of North America), Europe (U.K., Germany, France, Italy, Spain, Russia & Rest of Europe), Asia Pacific (China, Japan, India, Australia, Southeast Asia, & Rest of Asia Pacific), Latin America (Brazil, Mexico, & Rest of Latin America) and Middle East and Africa (Saudi Arabia, South Africa, UAE, & Rest of Middle East and Africa).

The report gives the pursuer the complete idea and understanding of the market and the regional and country level value and volume scenario and essentials for the industry. Current market insights on the regional level are studied and centered while market estimation, thus giving the reader a specialized idea & plans, financial as well as recent market advancements globally.

Contact Research Organization Services (CROs) Market Segmentation

By Type

Early Phase Development Services

o Discovery Studies

o Chemistry, Manufacturing & Control

o Preclinical Services

Pharmacokinetics/Pharmacodynamics (PK/PD)

Toxicology Testing

Others

Clinical Research Services

o Phase I

o Phase II

o Phase III

o Phase IV

Laboratory Services

o Bioanalytical Testing

o Analytical Testing

Physical Characterization

Stability Testing

Batch Release Testing

Raw Material Testing

Other Analytical Testing

Consulting Services

Data Management Services

By Therapeutic Area

Oncology

CNS Disorders

Metabolic Disorders

Infectious Diseases

Respiratory Disorders

CVS Disorders

Immunological Disorders

Ophthalmology

Other Therapeutic Areas

By End User

Medical Device Companies

Pharmaceutical and Biopharmaceutical Companies

Academic Institutes

By Region

North America

o U.S.

o Canada

o Rest of North America

Europe

o UK

o Germany

o France

o Italy

o Spain

o Russia

o Rest of Europe

Asia Pacific

o China

o Japan

o India

o Australia

o Southeast Asia

o Rest of Asia Pacific

Latin America

o Brazil

o Mexico

o Rest of Latin America

Middle East and Africa

o Saudi Arabia

o South Africa

o UAE

o Rest of Middle East and Africa

Table of Contents

1. Preface

1.1. Report Description and Scope

1.2. Research Scope

2. Research Methodology

2.1. Research Methodology

2.1.1. Market Research Process

2.1.2. Primary Research

2.1.3. Secondary Research

2.2. Models

2.2.1. Company Share Analysis Model

2.2.2. Revenue Based Model

2.3. Research limitations

3. Executive Summary

3.1. Global Market Overview and Executive Summary 2016 - 2027 (USD Billion)

3.2. Market Snapshot

4. Market Dynamics and Industry Analysis

4.1. Global Contract Research Organization Services Market: Introduction

4.2. Market Drivers

4.2.1. Increased Outsourcing of R&D Activities

4.2.2. Increasing Demand of Outsourcing Analytical Testing and Clinical Trial Services

4.2.3. Rise in Clinical Trials

4.2.4. Growing  R&D Expenditures

4.3. Market Restraint

4.3.1. Regulatory Pressure on CROs

4.3.2. Increasing Competition in the CRO Industry

4.4. Market Opportunity

4.4.1. Rising Demand for Specialized Testing Services

4.4.2. Growing Biosimilars and Biologics Market

4.5. Porter’s Five Forces Analysis

5. Trending Insights on Current Market Scenario

5.1. Current Market Trends

5.2. SWOT Analysis

5.3. PESTEL Analysis

6. Market Growth Attractiveness Analysis

6.1. Growth Attractiveness Analysis, by Type

6.2. Growth Attractiveness Analysis, by Therapeutic Area

6.3. Growth Attractiveness Analysis, by End User

6.4. Growth Attractiveness Analysis, by Region

7. Competitive Share Analysis

7.1. Company Share Analysis

7.1.1. Global Contract Research Organization Services Market: Company Market Share, 2019

7.2. Strategic Developments

7.2.1. Mergers and Acquisitions

7.2.2. New Product Launches

7.2.3. Partnerships, Collaborations and Joint Ventures

8. Global Contract Research Organization Services Market: Type Segment Analysis

8.1. Introduction

8.1.1. Market Revenue Share, by Type, 2019 & 2027 

8.1.2. Type Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.3. Early Phase Development Services

8.1.3.1. Early Phase Development Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.3.2. Discovery Studies

8.1.3.2.1. Discovery Studies in Early Phase Development Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.3.3. Chemistry, Manufacturing & Control

8.1.3.3.1. Chemistry, Manufacturing & Control in Early Phase Development Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.4. Preclinical Services

8.1.4.1. Preclinical Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.4.2. Pharmacokinetics/Pharmacodynamics (PK/PD)

8.1.4.2.1. Pharmacokinetics/Pharmacodynamics (PK/PD) in Preclinical Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.4.3. Toxicology Testing

8.1.4.3.1. Toxicology Testing in Preclinical Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.5. Clinical Research Services

8.1.5.1. Clinical Research Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.5.2. Phase I

8.1.5.2.1. Phase I in Clinical Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.5.3. Phase II

8.1.5.3.1. Phase II in Clinical Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.5.4. Phase III

8.1.5.4.1. Phase III in Clinical Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.5.5. Phase IV

8.1.5.5.1. Phase IV in Clinical Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.6. Laboratory Services

8.1.6.1. Laboratory Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.6.2. Bioanalytical Testing

8.1.6.2.1. Bioanalytical Testing in Laboratory Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.6.3. Stability Testing

8.1.6.3.1. Stability Testing in Laboratory Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.7. Batch Release Testing

8.1.7.1. Batch Release Testing Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.8. Analytical Testing

8.1.8.1. Analytical Testing Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.9. Physical Characterization

8.1.9.1. Physical Characterization Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.10. Raw Material Testing

8.1.10.1. Raw Material Testing Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.11. Consulting Services

8.1.11.1. Consulting Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.12. Data Management Services

8.1.12.1. Data Management Services Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

8.1.13. Other Analytical Testing

8.1.13.1. Other Analytical Testing Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9. Global Contract Research Organization Services Market: Therapeutic Area Segment Analysis

9.1. Introduction

9.1.1. Market Revenue Share, by Therapeutic Area, 2019 & 2027 

9.1.2. Therapeutic Area Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.3. Oncology

9.1.3.1. Oncology Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.4. CNS Disorders

9.1.4.1. CNS Disorders Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.5. Metabolic Disorders

9.1.5.1. Metabolic Disorders Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.6. Infectious Diseases

9.1.6.1. Infectious Diseases Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.7. Respiratory Disorders

9.1.7.1. Respiratory Disorders Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.8. Infectious Diseases

9.1.8.1. Infectious Diseases Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.9. CVS Disorders

9.1.9.1. CVS Disorders Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.10. Immunological Disorders

9.1.10.1. Immunological Disorders Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.11. Ophthalmology

9.1.11.1. Ophthalmology Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

9.1.12. Others

9.1.12.1. Others Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

10. Global Contract Research Organization Services Market: End User Segment Analysis

10.1. Introduction

10.1.1. Market Revenue Share, by End User, 2019 & 2027 

10.1.2. End User Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

10.1.3. Medical Device Companies

10.1.3.1. Medical Device Companies Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

10.1.4. Pharmaceutical and Biopharmaceutical Companies

10.1.4.1. Pharmaceutical and Biopharmaceutical Companies Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

10.1.5. Academic Institutes

10.1.5.1. Academic Institutes Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11. Global Contract Research Organization Services Market: Regional Analysis

11.1. Regional Overview

11.1.1. Market Revenue Share, by Region, 2019 & 2027 

11.1.2. Market Revenue Estimates and Forecast, by Region, 2016 - 2027 (USD Billion)

11.2. North America

11.2.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.2.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

11.2.3. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.2.4. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.2.5. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.2.6. U.S.

11.2.6.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.2.6.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.2.6.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.2.7. Canada

11.2.7.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.2.7.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.2.7.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.2.8. Rest of North America

11.2.8.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.2.8.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.2.8.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3. Europe

11.3.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.3.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

11.3.3. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.4. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.5. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3.6. Germany

11.3.6.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.6.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.6.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3.7. U.K.

11.3.7.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.7.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.7.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3.8. France

11.3.8.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.8.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.8.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3.9. Italy

11.3.9.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.9.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.9.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3.10. Spain

11.3.10.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.10.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.10.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3.11. Russia

11.3.11.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.11.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.11.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.3.12. Rest of Europe

11.3.12.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.3.12.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.3.12.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.4. Asia Pacific

11.4.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.4.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

11.4.3. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.4.4. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.4.5. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.4.6. China

11.4.6.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.4.6.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.4.6.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.4.7. Japan

11.4.7.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.4.7.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.4.7.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.4.8. India

11.4.8.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.4.8.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.4.8.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.4.9. Australia

11.4.9.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.4.9.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.4.9.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.4.10. Southeast Asia

11.4.10.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.4.10.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.4.10.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.4.11. Rest of Asia Pacific

11.4.11.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.4.11.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.4.11.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.5. Latin America

11.5.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.5.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

11.5.3. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.5.4. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.5.5. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.5.6. Brazil

11.5.6.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.5.6.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.5.6.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.5.7. Mexico

11.5.7.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.5.7.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.5.7.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.5.8. Rest of Latin America

11.5.8.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.5.8.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.5.8.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.6. Middle East and Africa

11.6.1. Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

11.6.2. Market Revenue Estimates and Forecast, by Country, 2016 - 2027 (USD Billion)

11.6.3. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.6.4. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.6.5. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.6.6. Saudi Arabia

11.6.6.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.6.6.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.6.6.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.6.7. South Africa

11.6.7.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.6.7.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.6.7.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.6.8. UAE

11.6.8.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.6.8.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.6.8.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

11.6.9. Rest of Middle East and Africa

11.6.9.1. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

11.6.9.2. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

11.6.9.3. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

12. Company Profiles

12.1. IQVIA (U.S.)

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Product Portfolio

12.1.4. Business Strategy

12.1.5. Recent Developments

12.2. WuXi AppTech (China)

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Product Portfolio

12.2.4. Business Strategy

12.2.5. Recent Developments

12.3. SGS (Switzerland)

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Product Portfolio

12.3.4. Business Strategy

12.3.5. Recent Developments

12.4. Charles River (U.S.)

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Product Portfolio

12.4.4. Business Strategy

12.4.5. Recent Developments

12.5. PAREXEL (U.S.)

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Product Portfolio

12.5.4. Business Strategy

12.5.5. Recent Developments

12.6. Syneos Health (U.S.)

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Product Portfolio

12.6.4. Business Strategy

12.6.5. Recent Developments

12.7. Medpace (U.S.)

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Product Portfolio

12.7.4. Business Strategy

12.7.5. Recent Developments

12.8. ICON Plc (Ireland)

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Product Portfolio

12.8.4. Business Strategy

12.8.5. Recent Developments

12.9. PPD (U.S.)

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Product Portfolio

12.9.4. Business Strategy

12.9.5. Recent Developments

12.10. PRA Health Sciences (U.S.)

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Product Portfolio

12.10.4. Business Strategy

12.10.5. Recent Developments

13. Market Effect Factor Analysis

14. Report Conclusion


List of Figures

1. Global Contract Research Organization Services Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

2. Porter’s Five Forces Analysis 

3. SWOT Analysis 

4. PESTEL Analysis

5. Company Share Analysis, 2019

6. Market Revenue Share Analysis, by Type, 2019 & 2027

7. Market Revenue Estimates and Forecast, by Early Phase Development Services, 2016 - 2027 (USD Billion)

8. Market Revenue Estimates and Forecast, by Preclinical Services, 2016 - 2027 (USD Billion)

9. Market Revenue Estimates and Forecast, by Clinical Research Services, 2016 - 2027 (USD Billion)

10. Market Revenue Estimates and Forecast, by Laboratory Services, 2016 - 2027 (USD Billion)

11. Market Revenue Estimates and Forecast, by Batch Release Testing, 2016 - 2027 (USD Billion)

12. Market Revenue Estimates and Forecast, by Analytical Testing, 2016 - 2027 (USD Billion)

13. Market Revenue Estimates and Forecast, by Physical Characterization, 2016 - 2027 (USD Billion)

14. Market Revenue Estimates and Forecast, by Raw Material Testing, 2016 - 2027 (USD Billion)

15. Market Revenue Estimates and Forecast, by Consulting Services, 2016 - 2027 (USD Billion)

16. Market Revenue Estimates and Forecast, by Data Management Services, 2016 - 2027 (USD Billion)

17. Market Revenue Estimates and Forecast, by Other Analytical Testing, 2016 - 2027 (USD Billion)

18. Market Revenue Share Analysis, by Therapeutic Area, 2019 & 2027

19. Market Revenue Estimates and Forecast, by Oncology, 2016 - 2027 (USD Billion)

20. Market Revenue Estimates and Forecast, by CNS Disorders, 2016 - 2027 (USD Billion)

21. Market Revenue Estimates and Forecast, by Metabolic Disorders, 2016 - 2027 (USD Billion)

22. Market Revenue Estimates and Forecast, by Infectious Diseases, 2016 - 2027 (USD Billion)

23. Market Revenue Estimates and Forecast, by Respiratory Disorders, 2016 - 2027 (USD Billion)

24. Market Revenue Estimates and Forecast, by CVS Disorders, 2016 - 2027 (USD Billion)

25. Market Revenue Estimates and Forecast, by Immunological Disorders, 2016 - 2027 (USD Billion)

26. Market Revenue Estimates and Forecast, by Ophthalmology, 2016 - 2027 (USD Billion)

27. Market Revenue Estimates and Forecast, by Other Therapeutic Areas, 2016 - 2027 (USD Billion)

28. Market Revenue Share Analysis, by End User, 2019 & 2027

29. Market Revenue Estimates and Forecast, by Medical Device Companies, 2016 - 2027 (USD Billion)

30. Market Revenue Estimates and Forecast, by Pharmaceutical and Biopharmaceutical Companies, 2016 - 2027 (USD Billion)

31. Market Revenue Estimates and Forecast, by Academic Institutes, 2016 - 2027 (USD Billion)

32. Market Revenue Share Analysis, by Region, 2019 & 2027

33. North America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

34. Europe Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

35. Asia Pacific Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

36. Latin America Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

37. Middle East and Africa Market Revenue Estimates and Forecast, 2016 - 2027 (USD Billion)

List of Tables

1. Global Contract Research Organization Services Market: Snapshot

2. Market Growth Drivers: Impact Analysis

3. Market Restraints: Impact Analysis

4. Market Revenue Estimates and Forecast, by Region, 2016 - 2027 (USD Billion)

5. Market Revenue Estimates and Forecast, by Type, 2016 - 2027 (USD Billion)

6. Market Revenue Estimates and Forecast, by Therapeutic Area, 2016 - 2027 (USD Billion)

7. Market Revenue Estimates and Forecast, by End User, 2016 - 2027 (USD Billion)

8. North America Market Size, by Country, 2016 - 2027 (USD Billion)

9. North America Market Size, by Type, 2016 - 2027 (USD Billion)

10. North America Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

11. North America Market Size, by End User, 2016 - 2027 (USD Billion)

12. U.S. Market Size, by Type, 2016 - 2027 (USD Billion)

13. U.S. Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

14. U.S. Market Size, by End User, 2016 - 2027 (USD Billion)

15. Canada Market Size, by Type, 2016 - 2027 (USD Billion)

16. Canada Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

17. Canada Market Size, by End User, 2016 - 2027 (USD Billion)

18. Rest of North America Market Size, by Type, 2016 - 2027 (USD Billion)

19. Rest of North America Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

20. Rest of North America Market Size, by End User, 2016 - 2027 (USD Billion)

21. Europe Market Size, by Country, 2016 - 2027 (USD Billion)

22. Europe Market Size, by Type, 2016 - 2027 (USD Billion)

23. Europe Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

24. Europe Market Size, by End User, 2016 - 2027 (USD Billion)

25. Germany Market Size, by Type, 2016 - 2027 (USD Billion)

26. Germany Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

27. Germany Market Size, by End User, 2016 - 2027 (USD Billion)

28. U.K. Market Size, by Type, 2016 - 2027 (USD Billion)

29. U.K. Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

30. U.K. Market Size, by End User, 2016 - 2027 (USD Billion)

31. France Market Size, by Type, 2016 - 2027 (USD Billion)

32. France Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

33. France Market Size, by End User, 2016 - 2027 (USD Billion)

34. Italy Market Size, by Type, 2016 - 2027 (USD Billion)

35. Italy Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

36. Italy Market Size, by End User, 2016 - 2027 (USD Billion)

37. Spain Market Size, by Type, 2016 - 2027 (USD Billion)

38. Spain Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

39. Spain Market Size, by End User, 2016 - 2027 (USD Billion)

40. Russia Market Size, by Type, 2016 - 2027 (USD Billion)

41. Russia Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

42. Russia Market Size, by End User, 2016 - 2027 (USD Billion)

43. Rest of Europe Market Size, by Type, 2016 - 2027 (USD Billion)

44. Rest of Europe Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

45. Rest of Europe Market Size, by End User, 2016 - 2027 (USD Billion)

46. Asia Pacific Market Size, by Country, 2016 - 2027 (USD Billion)

47. Asia Pacific Market Size, by Type, 2016 - 2027 (USD Billion)

48. Asia Pacific Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

49. Asia Pacific Market Size, by End User, 2016 - 2027 (USD Billion)

50. China Market Size, by Type, 2016 - 2027 (USD Billion)

51. China Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

52. China Market Size, by End User, 2016 - 2027 (USD Billion)

53. Japan Market Size, by Type, 2016 - 2027 (USD Billion)

54. Japan Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

55. Japan Market Size, by End User, 2016 - 2027 (USD Billion)

56. India Market Size, by Type, 2016 - 2027 (USD Billion)

57. India Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

58. India Market Size, by End User, 2016 - 2027 (USD Billion)

59. Australia Market Size, by Type, 2016 - 2027 (USD Billion)

60. Australia Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

61. Australia Market Size, by End User, 2016 - 2027 (USD Billion)

62. Southeast Asia Market Size, by Type, 2016 - 2027 (USD Billion)

63. Southeast Asia Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

64. Southeast Asia Market Size, by End User, 2016 - 2027 (USD Billion)

65. Rest of Asia Pacific Market Size, by Type, 2016 - 2027 (USD Billion)

66. Rest of Asia Pacific Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

67. Rest of Asia Pacific Market Size, by End User, 2016 - 2027 (USD Billion)

68. Latin America Market Size, by Country, 2016 - 2027 (USD Billion)

69. Latin America Market Size, by Type, 2016 - 2027 (USD Billion)

70. Latin America Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

71. Latin America Market Size, by End User, 2016 - 2027 (USD Billion)

72. Brazil Market Size, by Type, 2016 - 2027 (USD Billion)

73. Brazil Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

74. Brazil Market Size, by End User, 2016 - 2027 (USD Billion)

75. Mexico Market Size, by Type, 2016 - 2027 (USD Billion)

76. Mexico Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

77. Mexico Market Size, by End User, 2016 - 2027 (USD Billion)

78. Rest of Latin America Market Size, by Type, 2016 - 2027 (USD Billion)

79. Rest of Latin America Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

80. Rest of Latin America Market Size, by End User, 2016 - 2027 (USD Billion)

81. Middle East and Africa Market Size, by Country, 2016 - 2027 (USD Billion)

82. Middle East and Africa Market Size, by Type, 2016 - 2027 (USD Billion)

83. Middle East and Africa Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

84. Middle East and Africa Market Size, by End User, 2016 - 2027 (USD Billion)

85. Saudi Arabia Market Size, by Type, 2016 - 2027 (USD Billion)

86. Saudi Arabia Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

87. Saudi Arabia Market Size, by End User, 2016 - 2027 (USD Billion)

88. South Africa Market Size, by Type, 2016 - 2027 (USD Billion)

89. South Africa Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

90. South Africa Market Size, by End User, 2016 - 2027 (USD Billion)

91. UAE Market Size, by Type, 2016 - 2027 (USD Billion)

92. UAE Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

93. UAE Market Size, by End User, 2016 - 2027 (USD Billion)

94. Rest of Middle East and Africa Market Size, by Type, 2016 - 2027 (USD Billion)

95. Rest of Middle East and Africa Market Size, by Therapeutic Area, 2016 - 2027 (USD Billion)

96. Rest of Middle East and Africa Market Size, by End User, 2016 - 2027 (USD Billion)


Payment Details